The global postpartum hemorrhage treatment devices market is progressing at a CAGR of 4.9% within a forecast period of 2015 to 2023. Owing to this positive growth rate, the market is expected to reach US$926.1 mn before the end of 2023. The global postpartum hemorrhage treatment devices market was recorded at US$604.4 mn in 2014, according to a research report released by Transparency Market Research. The report, titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023,” is an all-inclusive analytical guideline for any client who wishes to create a stronger business position within this market.
Obtain Report Details @
A patient is diagnosed with postpartum hemorrhage only after there has been a loss of at least 500 ml of blood after a vaginal delivery, and at least 1,000 ml in the case of cesarean delivery, both within a certain time frame. If the mother has lost the specified amount of blood within 24 hours of delivery, it is known as primary PPH, while it is classified as secondary PPH if she bleeds after 24 hours of delivery.
According to the report, the global postpartum hemorrhage treatment devices market is primarily being driven by the rising cases of PPH across the world. This market is also benefitting from the increased investment efforts taken up by multiple governments, along with the steadily growing education programs and awareness towards the complications caused by PPH and the various treatment solutions available.
The global postpartum hemorrhage treatment devices market is currently, however, still facing the major hindrance of a very low awareness rate. This applies especially to developing economies where the market is stifled by a high rate of social rejection rates related to any modern and unconventional treatments and preventive devices.
The report divides the global postpartum hemorrhage treatment devices market on the basis of products into uterine balloon tamponade, Uniject prefilled infection systems, and non-pneumatic anti-shock garments. The segment of uterine balloon tamponades led the market in 2014 owing to low cost and a higher availability rate. The segment of Uniject prefilled injection systems is exhibiting the fastest growth rate for the report’s forecast period.
Geographically, the global postpartum hemorrhage treatment devices market was led by North America in 2014 owing to several factors. These include the rising number of PPH cases and related maternal mortality rate along with the higher availability of modern and advanced healthcare. At the same time, Asia Pacific is expected to report the fastest growth rate due to a rapidly increasing awareness rate and major improvements in healthcare infrastructure. Another factor to consider, especially for developing economies such as Hong Kong, China, and India, is the high rate of anemia among women. More than 60% of the average population of women is suffering from anemia, which is one of the leading causes of PPH.
The key players in the global postpartum hemorrhage treatment devices market are discussed in detail within the report. These include Zoex, Utah Medical Products, Inc., Teleflex Incorporated, Program for Appropriate Technology in Health (PATH), C. R. Bard, Inc., Cook Medical, Inc., Bactiguard AB, and 3rd Stone Design, Inc.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.